Adjuvant fractionated high-dose-rate int
✍
Jiade J. Lu; Thomas P. Shakespeare; Luke Kim Siang Tan; Boon Cher Goh; Jay S. Co
📂
Article
📅
2004
🏛
John Wiley and Sons
🌐
English
⚖ 120 KB
## Abstract ## Background. The value of high‐dose‐rate intracavitary brachytherapy (HDRIB) for persistent or recurrent nasopharyngeal carcinoma has been well described; however, the benefit of routine adjuvant fractionated HDRIB following external beam radiation therapy (EBRT) has not been complet